Concepedia

Zbigniew Gaciong

ZG

Statistics

Publications

40

Citations

2.6K

H-Index

24

Active since

1990

Affiliations

Medical University of Warsaw(Current)

University of Southern California

University of Oslo

Gdańsk Medical University

Institute of Cardiology

Zbigniew Gaciong is an author at Medical University of Warsaw specializing in medicine, cardiology, and nephrology.

Publications per year

1990–2023

40

Publications

40

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

Robert P. Giugliano, Terje R. Pedersen, Jeong-Gun Park et al. · The Lancet · 2017 · 677 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 227 citations · Full text

Medicine, Cardiology, Pharmacology +14

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 200 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE

Prakriti Gaba, Michelle L. O’Donoghue, Jeong‐Gun Park et al. · Circulation · 2023 · 173 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial

Brian A. Bergmark, Michelle L. O’Donoghue, Sabina A. Murphy et al. · JAMA Cardiology · 2020 · 131 citations · Full text

Medicine, Cardiology, Pharmacology +17

1–5 of 40